Scarica l'app Stockscreener
4.06
8.76%
-0.39
Dopo l'orario di chiusura:
4.19
0.13
+3.20%
Abpro Holdings Inc Borsa (ABP) Ultime notizie
Can Abpro Holdings Inc. Equity Warrant stock outperform in 2025 bull marketWeekly Trade Report & Safe Capital Growth Tips - ulpravda.ru
Is Orchestra BioMed Holdings Inc. stock a dividend growth opportunityJuly 2025 Update & Daily Chart Pattern Signal Reports - ulpravda.ru
What momentum indicators show for Abpro Holdings Inc. stockJuly 2025 PreEarnings & Growth Oriented Trade Recommendations - ulpravda.ru
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Abpro stock rises after FDA clearance for solid tumor program By Investing.com - Investing.com South Africa
Abpro stock rises after FDA clearance for solid tumor program - Investing.com
FDA clears Abpro and Celltrion’s solid tumor therapy for clinical trial - Investing.com Australia
FDA Clears Abpro’s Lead HER2 Cancer Drug for Phase 1 - TipRanks
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72 - The Manila Times
Published on: 2025-12-30 01:00:17 - moha.gov.vn
Aug Levels: Why Abpro Holdings Inc stock could rally in 2025July 2025 Price Swings & AI Forecasted Entry/Exit Points - moha.gov.vn
Abpro Holdings Inc. (NASDAQ:ABP) Short Interest Update - Defense World
Aug Selloffs: How Abpro Holdings Inc. Equity Warrant stock reacts to job market dataTrade Volume Report & Fast Gain Stock Tips - Улправда
How Abpro Holdings Inc. Equity Warrant stock valuations compare to rivalsQuarterly Profit Report & Expert Curated Trade Ideas - Улправда
Why Abpro Holdings Inc. stock is a value investor pickCPI Data & Technical Pattern Recognition Alerts - Улправда
Is Abpro Holdings Inc. Equity Warrant stock a smart buy before Fed meetingTrade Risk Assessment & Weekly Momentum Picks - Улправда
How Abpro Holdings Inc. stock compares to industry benchmarksJuly 2025 Selloffs & Weekly Chart Analysis and Guides - Улправда
How Abpro Holdings Inc. Equity Warrant stock benefits from tech adoptionQuarterly Trade Report & Free Weekly Watchlist of Top Performers - Улправда
Net current asset value per share of Abpro Holdings, Inc. Warrant 2024-12.11.29 on Abpro Hldgs – NASDAQ:ABPWW - TradingView — Track All Markets
How Abpro Holdings Inc. Equity Warrant stock reacts to job market dataJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
Can Abpro Holdings Inc. Equity Warrant stock rebound after recent weaknessQuarterly Trade Summary & Free Growth Oriented Trading Recommendations - Улправда
What Wall Street predicts for Abpro Holdings Inc. stock priceTrade Performance Summary & Daily Growth Stock Investment Tips - DonanımHaber
Why Abpro Holdings Inc. Equity Warrant stock remains undervalued - Улправда
How interest rate cuts could boost Abpro Holdings Inc. stockWeekly Profit Report & Safe Capital Growth Plans - DonanımHaber
Abpro (NASDAQ:ABP) Stock Price Up 0.2% – Still a Buy? - Defense World
Chipmakers Recap: How Abpro Holdings Inc. stock compares to industry benchmarks2025 Volatility Report & Target Return Focused Stock Picks - Улправда
Abpro Hldgs (ABP) Stock Analysis Report | Financials & Insights - Benzinga
Aug Patterns: How Abpro Holdings Inc. Equity Warrant stock valuations compare to rivals2025 Market Sentiment & AI Forecasted Stock Moves - ulpravda.ru
Abpro and Celltrion announce IND filing for T-cell engager - BioWorld MedTech
Abpro Holdings submits IND application for Phase 1 trial of ABP102/CT-P72 - TipRanks
Abpro Holdings Submits IND Application for Cancer Drug - TipRanks
Abpro Holdings, Inc. Submits IND for Phase 1 Trial of ABP-102/CT-P72 - TradingView — Track All Markets
Abpro Holdings (NASDAQ: ABP) discloses IND filing for HER2 therapy - Stock Titan
Abpro Holdings announces submission of an IND application to initiate a Phase 1 clinical trial of T cell engager ABP-102/CT-P72 for HER2-positive cancers - marketscreener.com
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers - TradingView — Track All Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Abpro Holdings Announces Submission of an IND Application - GlobeNewswire
Abpro secures NASDAQ extension to regain compliance with listing rules - MSN
Abpro Holdings Granted Nasdaq Compliance Extension - TipRanks
Abpro Holdings granted Nasdaq compliance extension - MSN
Abpro Holdings, Inc. Granted Nasdaq Listing Extension - TradingView — Track All Markets
Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives - marketscreener.com
Fed Watch: Will Abpro Holdings Inc stock reach all time highs in 2025Trade Entry Report & Fast Momentum Stock Entry Tips - moha.gov.vn
What catalysts could drive Abpro Holdings Inc. stock higherFed Meeting & High Return Stock Watch Alerts - Newser
How Abpro Holdings Inc. stock performs in rate cut cyclesJuly 2025 Pullbacks & Reliable Breakout Forecasts - Newser
How Abpro Holdings Inc. stock performs in weak economyJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Can Abpro Holdings Inc. stock outperform in 2025 bull marketForecast Cut & High Win Rate Trade Alerts - Newser
Will Abpro Holdings Inc. stock reach all time highs in 2025Quarterly Risk Review & Real-Time Volume Trigger Notifications - Newser
Can Abpro Holdings Inc. Equity Warrant stock maintain operating marginsJuly 2025 Summary & Expert-Curated Trade Recommendations - moha.gov.vn
Wall Street Recap: How Abpro Holdings Inc. stock compares to industry benchmarksAnalyst Downgrade & Real-Time Sentiment Analysis - BỘ NỘI VỤ
Abpro (ABP) versus Its Competitors Head to Head Review - Defense World
Abpro Holdings, Celltrion to present preclinical data for CT-P72/ABP-102 - MSN
Can Abpro Holdings Inc. rally from current levelsAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Is Abpro Holdings Inc. stock resilient to inflation2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):